cyclopentane has been researched along with ketamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baimbridge, KG; Church, J; Shacklock, JA | 1 |
Cho, KP; Eun, YA; Kim, DC; Kim, HI; Kim, KW; Kim, YH | 1 |
Aluko, OM; Annafi, OS; Eduviere, AT; Omorogbe, O; Umukoro, S | 1 |
3 other study(ies) available for cyclopentane and ketamine
Article | Year |
---|---|
Dextromethorphan and phencyclidine receptor ligands: differential effects on K(+)- and NMDA-evoked increases in cytosolic free Ca2+ concentration.
Topics: Animals; Calcium; Cyclopentanes; Cytosol; Dextromethorphan; Female; Fura-2; Hippocampus; Ketamine; Ligands; N-Methylaspartate; Parasympatholytics; Potassium; Pregnancy; Pyramidal Tracts; Rats; Receptors, Neurotransmitter; Receptors, Phencyclidine | 1991 |
Ca2+-dependent and -independent mechanisms of ischaemia-evoked release of [3H]-dopamine from rat striatal slices.
Topics: Animals; Brain Ischemia; Calcium; Calcium Channel Blockers; Corpus Striatum; Culture Techniques; Cyclopentanes; Dantrolene; Dizocilpine Maleate; Dopamine; Ketamine; Magnesium Sulfate; Nomifensine; omega-Conotoxin GVIA; Peptides; Quinoxalines; Rats; Tetrodotoxin; Verapamil | 1995 |
Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.
Topics: Acetates; Animals; Antioxidants; Antipsychotic Agents; Brain; Bromocriptine; Cyclopentanes; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ketamine; Locomotion; Male; Maze Learning; Memory; Memory Disorders; Mice; Oxidative Stress; Oxylipins; Psychotic Disorders; Stereotyped Behavior; Time Factors | 2017 |